Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
AAOHN Journal : Official Journal of the American Association of Occupational Health Nurses|June 27, 2008
Workplace health promotion--strategies for low-income Hispanic immigrant womenPerla Zarate-Abbott, Annette Etnyre, Irene Gilliland, et al.
Therapeutic Advances in Respiratory Disease|October 30, 2020
Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACTJosé M Marín, Luis Mateos, Juan Roldán, et al.
Applied Nursing Research : ANR|October 31, 2009
An exploratory study of cardiac health in college athletesLaura Muñoz, Gary Norgan, Maureen Rauschhuber, et al.
The European Respiratory Journal|April 18, 2020
The effect of exacerbation history on outcomes in the IMPACT trialDavid M G Halpin, Mark T Dransfield, MeiLan K Han, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2020
The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical TrialMeiLan K Han, Gerard J Criner, Mark T Dransfield, et al.
Advances in Therapy|July 11, 2020
Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT StudyMaggie Tabberer, C Elaine Jones, Sally Kilbride, et al.
Respiratory Research|June 7, 2020
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trialNicola C Day, Subramanya Kumar, Gerard Criner, et al.
Pulmonary Therapy|November 17, 2020
Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT TrialDavid M G Halpin, Gerard J Criner, Mark T Dransfield, et al.
Chest|October 8, 2020
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment TrialNicola A Hanania, David M Mannino, Gerard J Criner, et al.
Annals of the American Thoracic Society|October 27, 2020
Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACTMark T Dransfield, Courtney Crim, Gerard J Criner, et al.
Pageof 5